Union Minister Nitin Gadkari on Day 1 of the 2024 edition of the Hindustan Times Leadership Summit, highlighted the ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Bluebird Bio (BLUE) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.66 per share a year ago. These figures are ...

Analysts estimate that Bio-Path Holdings will report an earnings per share (EPS) of $-1.02. Anticipation surrounds Bio-Path ...

The Biotechnology Innovation Organization (BIO) has commended a recent update from the USDA's Animal and Plant Health Inspection Service (APHIS), which has expanded exemptions for genetically modified ...

Ever since Mob of the Dead back in Black Ops 2, the Jumpscare has become a reoccurring Easter Egg in many Zombies maps and it makes a return on Terminus inBlack Ops 6 Zombies. Thi ...

The U.S. Department of Energy is ponying up $10 for Prometheus Materials Inc., a zero-carbon building materials company, and ...

CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay kit: ...

SOMERVILLE, Mass. (AP) — SOMERVILLE, Mass. (AP) — Bluebird Bio Inc. (BLUE) on Thursday reported a loss of $60.8 million in its third quarter. On a per-share basis, the Somerville, Massachusetts-based ...

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported third quarter results and business highlights for the quarter ended September 30, 2024, including recent commercial ...

There is a link on our Facebook page that you can share and you can also find the link it in our instagram bio until the ...

Dow’s reversible cross-linking resins are an innovative solution enabling footwear materials that are designed for ...